Intestinal tracts of wild catfish can be a potential source of antimicrobials-producing bacteria as probiotic candidates to replace the indiscriminative use of antibiotics in aquaculture industries (Sahoo et al., 2016). Among the available bacterial strains, lactic acid bacteria have been commonly targeted by many researchers due to their ability to produce a variety of antimicrobial compounds, and are generally regarded as safe (GRAS) microorganisms (Amin et al., 2020; Hernández-González et al., 2021). In addition, LAB members are well known for their ability to cope with a wide range of environmental conditions including fish skin, gills, and intestinal tracts (Merrifield et al., 2014; Araujo et al., 2015; Amin et al., 2020; Li et al., 2020), which were considered as common entry points for many bacterial pathogens. The present study isolated six LABs having the capacity to produce anti-erdwadsiella compounds, identified as L. lactis ZMW55, E. hirae ZMW94, W. confusa ZMW101, W. cibaria ZMW102 and two strains of E. faecalis ZMW50 and E. faecalis ZMW96. Of these, four LABs (Enterococcus hirae ZMW94, E. faecalis ZMW50, Lactococcus lactis ZMW55, and Weissella confusa ZMW101) appeared to be potential probionts (having anti-erdwasiella activity, able to tolerate harsh environmental conditions of simulated stomach and intestina juice, susceptible to antibiotics, and non pathogens. While the other two LAB strains (E. faecalis ZMW96 and W. cibaria ZMW102) were excluded due to carrying antibiotic resistance genes to Novobiocin and Enrofloxacin respectively.
Three enterococci (2 strains E. faecalis, and one strain of E. hirae) isolated in the present study seemed to be quite common reported in previous studies. A study by Muñoz-Atienza et al. (2013), for instance, reported E. faecalis AP45 isolated from the intestinal tract of Cod (Gadus morhua), produced antimicrobial compounds against Clostridium perfringens, and L. monocytogenes. Additionally, E. faecalis has also been reported to have inhibitory activity against several fish pathogens such as Aeromonas hydrophila, Pseudomonas aureginosa, Shewanella putrefaciens (Allameh et al., 2017). Another by Muñoz-Atienza et al. (2013) showed E. faecalis inhibited several fish pathogens including Lactococcus garvieae, Streptococcus iniae, and Listonella anguillarum. Similarly, E. faecium NRW-2 was reported to inhibit the growth of Vibrio harveyi and Vibrio parahaemolyticus in white shrimp, Litopenaesu vannamei (Hernández-González et al., 2021).
Another potential species isolated in the present study was identified as L. lactis ZMW55. This species was also reported from many freshwater species such as tilapia (Oreochromis niloticus) and catfish (Clarias batrachus) (Loh et al., 2014; Kaktcham et al., 2019). In addition, L. lactis subsp. lactis CF4MRS isolated from gastrointestinal Clarias batrachus had a capcity to produce various antimicrobial compounds that can potentially be useful in controlling bacterial pathogen such as Edwardsiella tarda, Pseudomonas fluorescens and Serratia marcescens (Loh et al., 2014). Furthermore, Muñoz-Atienza et al. (2013) reported that Lactococcus strains isolated from fish were reported to be sensitive to ciprofloxacin, erythromycin, gentamicin, nitrofurantoin, tetracycline, and vancomycin.
The other potential species was identified as Weissella confusa ZMW101. This species was also generally isolated from fish and shellfish in saltwater fish (Muñoz-Atienza et al., 2013), and synthesize diverse antibacterial compounds toward different fish bacterial pathogens (Ringø et al., 2018). A study by Prachom et al. (2020) showed that Weisella sp. isolated from the digestive tract of tilapia was found to be able to suppress the growth of B. subtilis, M. morganii, and E. coli. Similar studies by Bukhori and Sartini (2020) also reported that Weisella sp. isolated from the intestinal tract of Nile Tilapia was able to inhibit two common pathogens (Staphilococcus aureus and Shigella sp). The present study showed also that W. confusa was safe for catfish. These results are consistent with previous studies where W. confusa-supplemented diet and fed on rainbow trout (Oncorhynchus mykiss) increased growth performance, serum immune parameters, immune gene expression, and gut microbiota. These results confirm the benefits of using W. confusa as a probiotic in rainbow trout (Kahyani et al., 2021).
Besides having antagonistic activity against bacterial pathogens, probiotic candidates should be able to survive under gastrointestinal conditions (Geraylou et al., 2014; Amin et al., 2016). The result of our evaluation suggests that six LAB were able to survive in stomach conditions, although their viability slightly decreased except for L. lactis. However, after the simulation of intestinal juice, the viability of bacteria increased. These results suggest that the growth of LAB was affected by low pH and bile salt. A similar outcome has been reported for LAB in an acidic environment (Ramos et al., 2013) (Ramos et al., 2013; Tokatli et al., 2015; Mubarak dan Soraya, 2018). Another criterion when selecting probiotics is to survive and adhere to intestinal so that they can colonize and compete with pathogens for adhesion sites and nutrients (Amin et al., 2017). A different strain of bacteria could have a different ability to tolerate bile salt and adhere to the intestinal mucosa (Tokatlı et al., 2015). The ability to tolerate bile salt might be because these bacteria produce bile salt hydrolase (Ru et al., 2019). The adhesion capacity of six LAB varied from 3,42% to 16,72%. These variations are consistent with the variation in the mucus-adhering capacity of eight probiotic candidates isolated from Acipenser baeri ranging from 0.86% − 10.09% ((Geraylou et al., 2014). While the percentage of LAB attachment to the intestinal mucus of Atlantic salmon was 8.8%, 24%, and 36.1% for L. farraginis, P. acidilactici, and P. pentosaceus, respectively (Amin et al., 2016). Differences in adhesion capacity between bacterial strains might due to the presence of specific receptors on bacteria in intestinal mucus or specific carbohydrate molecules on the surface of bacterial components that act as mediators for adherence to mucus (Geraylou et al., 2014; Muscariello et al., 2020).
The antagonistic activity of LABs identified in the present study can be due to several compounds such as hydrogen peroxide, fatty acids, organic acids, ethanol, antibiotics, and bacteriocin-like inhibitory substances (BLIS) (Madigan et al., 2018). The antimicrobial activity of cell-free supernatant (CFS) from six LAB was observed after pH neutralization which indicated that these LAB strains produced other antimicrobial compounds besides the organic acids such as BLIS (Amin et al., 2016). Bacteriocins are ribosomal-synthesized antimicrobial peptides (Sahoo et al., 2016). Enterocin is commonly bacteriocin produced by Enterococcus, lacticin, and nisin by Lactococcus, and plantaricin by Lactobacillus (Sahoo et al., 2016; Hernández-González et al., 2021). Another antimicrobial peptide from the genus Weissella was Weissellicin and Weisselin (Fusco et al., 2015). However, further studies are still required to identify bacteriocin-like inhibitory substances produced by each isolated LAB.
In conclusion, the present study isolated three lactic acid bacteria (L. lactis, E. hirae and W. confusa) and showed potential characteristics for probiotic candidates: antagonistic to-Edwardsiella ictaluri, able to tolerate harsh environmental conditions of the stomach and intestinal conditions, good adhesion capacity to intestinal mucus, susceptible to antibiotics, and safe for catfish. However, these study was based solely on in vivo studies; therefore in vivo trials on how these LABs might protect catfish from enteric septicaemia of catfish disease should be further investigated.